http://rdf.ncbi.nlm.nih.gov/pubchem/patent/IE-911519-A1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ff81a650b70e913d3b2524b45e4c7320 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-65 |
| filingDate | 1991-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_10df5e3eb893b8c0afbb6d99d7dd0a04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2b0803a7d23ad1bec59c72fb883bf315 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f736fd59ebf2036ed2838d0de15722ce http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_109e076ce721ddb8fb1bdf7f45ae5ff3 |
| publicationDate | 1992-11-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | IE-911519-A1 |
| titleOfInvention | A Novel Anti-Collagenolytic Formulation for the Treatment of¹Chronic Inflammatory Diseases |
| abstract | A method for treating mammals suffering from 5 rheumatoid arthritis and other tissue-destructive (chronic inflammatory or other) conditions associated with excess metalloproteinase activity comprising administering to the mammal an amount of a tetracycline that is effectively antimetalloproteinase, but that is not effectively antimicrobial, and an amount of non-steroidal anti-inflammatory agent which, when combined with the effectively anti-metalloproteinase amount of tetracycline, results in a significant reduction of 15 tissue destruction and/or bone loss. |
| priorityDate | 1991-05-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 76.